Filing Flows › Elanco Animal Health (ELAN) › Q2 2025
Elanco Animal Health (ELAN) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
Elanco Animal Health (ELAN) reported revenue of $1.2B for the second quarter 2025 (Q2 2025), +5% from a year earlier and +4% from the quarter before. Operating margin was 2.0%, net earnings $11.0M (0.9% of revenue).
Elanco Animal Health, Q2 2025: revenue $1.2B (+5% year over year), operating margin 2.0%, net earnings $11.0M, operating cash flow $237M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2B | +4% | +5% |
| Gross profit | $713M | +4% | +3% |
| Operating profit | $25.0M | -58% | — |
| Net earnings | $11.0M | -84% | — |
| Operating cash flow | $237M | — | +19% |
| Free cash flow | $180M | — | +8% |
What changed
Revenue was $1.2B in Q2 2025, up 5% year over year and up 4% from the previous quarter. Pet Health was the largest line at 52% of revenue. Pet Health added $0.06B year over year (up 11%), 112% of the total change.
Gross margin was 57.5%, down 0.7 points from a year earlier. Operating profit was $0.03B, a 2.0% margin (up 4.7 points year over year). Operating expenses fell 5% while revenue rose 5%. The fastest-growing cost line was SG&A (+13%). Net earnings were $0.01B. The effective tax rate was 56.0%.
Operating cash flow was $0.24B (up 19% year over year), 2155% of net earnings. Non-cash charges added back $0.17B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.04B. Capital expenditures of $0.06B left free cash flow of $0.18B.
Questions
What was Elanco Animal Health's revenue in the second quarter 2025?
Elanco Animal Health (ELAN) reported revenue of $1.2B for the second quarter 2025 (Q2 2025), +5% from a year earlier and +4% from the quarter before.
Was Elanco Animal Health profitable in the second quarter 2025?
Operating profit was $25.0M (2.0% of revenue) and net earnings $11.0M.